Anesthesiology, Pain Medicine · Texarkana, TX
NPI
1639143829
Since 2006
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
5950 Summerhill Rd
Texarkana, TX, 75503
Phone (844) 215-0731
Groups this clinician bills Medicare through
Medicare paid, 2024
$671K
11,828 services
Medicare patients, 2024
438
Average age 65
Drug cost, 2024
$268K
10,073 prescriptions
Company payments, 2025
$403
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohammed A Khanzada was code 80307 (drug tests), 1,707 times for 400 patients. In total Mohammed A Khanzada billed 11,828 services in 62 codes, and Medicare paid $671K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 80307 Drug Tests | Office | 1,707 | 400 | $60.24 | $103K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 1,410 | 390 | $189.65 | $267K |
| 99214 Office E&M - Established | Office | 1,375 | 387 | $75.58 | $104K |
| 36415 Venipuncture Blood Collection | Office | 463 | 320 | $8.48 | $3,926 |
| 82607 Clinical Chemistry | Office | 458 | 324 | $14.41 | $6,599 |
| 84403 Clinical Chemistry | Office | 457 | 325 | $24.61 | $11K |
| 82977 Clinical Chemistry | Office | 457 | 323 | $6.88 | $3,145 |
| 84100 Clinical Chemistry | Office | 456 | 325 | $4.52 | $2,063 |
| 83735 Clinical Chemistry | Office | 454 | 325 | $6.39 | $2,902 |
| 82306 Clinical Chemistry | Office | 453 | 323 | $28.31 | $13K |
| 86140 Clinical Chemistry | Office | 452 | 324 | $4.94 | $2,233 |
| 82746 Clinical Chemistry | Office | 451 | 324 | $14.02 | $6,321 |
| 80053 Clinical Chemistry | Office | 444 | 317 | $10.20 | $4,528 |
| 84443 Clinical Chemistry | Office | 433 | 317 | $16.18 | $7,006 |
| 85027 Blood Count | Office | 427 | 313 | $6.26 | $2,672 |
By year: 2022 $565K for 5,773 services; 2023 $632K for 6,937 services; 2024 $671K for 11,828 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 1,707 | 400 | $60.24 | $103K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 1,410 | 390 | $189.65 | $267K |
| 36415 Venipuncture Blood Collection | 463 | 320 | $8.48 | $3,926 |
| 82607 Clinical Chemistry | 458 | 324 | $14.41 | $6,599 |
| 84403 Clinical Chemistry | 457 | 325 | $24.61 | $11K |
| 82977 Clinical Chemistry | 457 | 323 | $6.88 | $3,145 |
| 84100 Clinical Chemistry | 456 | 325 | $4.52 | $2,063 |
| 83735 Clinical Chemistry | 454 | 325 | $6.39 | $2,902 |
| 82306 Clinical Chemistry | 453 | 323 | $28.31 | $13K |
| 86140 Clinical Chemistry | 452 | 324 | $4.94 | $2,233 |
Medicare prescription drug claims, 2024
In 2024, the drug Mohammed A Khanzada prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 7,277 prescriptions and refills. In total Mohammed A Khanzada wrote 10,073 Medicare prescriptions that cost $268K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 7,277 | 7,287 | 868 | $204K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 702 | 702 | 89 | $22K |
| Tramadol Hcl Generic | 271 | 272 | 84 | $2,308 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 255 | 255 | 79 | $4,972 |
| Tizanidine Hcl Generic | 252 | 257 | 89 | $2,181 |
| Oxycodone Hcl Generic | 251 | 251 | 31 | $3,851 |
| Gabapentin Generic | 212 | 227 | 83 | $2,423 |
| Pregabalin Generic | 142 | 148 | 40 | $2,151 |
| Morphine Sulfate Er Morphine Sulfate | 109 | 111 | 12 | $4,347 |
| Cyclobenzaprine Hcl Generic | 98 | 100 | 36 | $937 |
| Methocarbamol Generic | 80 | 80 | 30 | $1,053 |
| Meloxicam Generic | 59 | 64 | 20 | $156 |
| Naloxone Hcl Generic | 56 | 56 | 54 | $3,380 |
| Baclofen Generic | 51 | 59 | 22 | $639 |
| Morphine Sulfate Generic | 46 | 46 | Under 11 | $1,479 |
Brand drugs: 49 claims; generic drugs: 10,024 claims; opioid claims: 8,976.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohammed A Khanzada $403 ($403 in general payments such as food, travel and fees) from 4 companies. The largest payer was Stryker Corporation with $287.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.